Skip to main content
. 2019 Aug 19;13(6):1037–1048. doi: 10.1093/ckj/sfz098

FIGURE 7.

FIGURE 7

(a) HbA1c, (b) fasting glucose, (c) cholesterol and (d) BMI at baseline and 3 months of patients receiving potassium citrate therapy (Group C). Plot shows the mean ± SD. No significant changes were observed.